Award
Award 36C25026C0012 — CYTOPATH BIOPSY LAB INC
- Awarded to
- CYTOPATH BIOPSY LAB INC
- Agency
- Department of Veterans Affairs
- Estimated value
- $143,500
THYROSEQ V3 GENOMIC CLASSIFIER THYROID TESTING
Key dates
- Award date
- October 3, 2025
- Performance start
- October 3, 2025
- Performance end
- October 2, 2027
Who is this buyer
Organization
Buying history
- Records370 total
- Opportunities / awards5 / 184
- Value range$0 – $14,851,013
- ActiveMay 5, 2026 – October 26, 2026
What they buy
- Clinical (298)
- Administrative (69)
- Insurance (3)
Set-asides used
- No Set aside used (31)
- Small Business Set Aside - Total (31)
- SDVOSB Set-Aside (FAR 19.14) (12)
- VOSB Set-Aside (VA) (1)
Who holds their work today
- LABORATORY CORPORATION OF AMERICA8 wins · $17,000,985 · last August 31, 2026
- LC FLUHARTY CONSTRUCTION LLC1 win · $14,851,013 · last October 16, 2026
- MCLAREN PORT HURON3 wins · $10,935,821 · last October 1, 2026
- ARUP LABORATORIES INC9 wins · $7,240,551 · last November 1, 2025
- VETMED GROUP LLC2 wins · $6,808,913 · last May 1, 2026
Also open from this buyer
- WatchPat One Direct Program Roudebush VA Medical Center Indianapolis, INDue October 29, 2026 · Clinical
- Rehabilitation Equipment - High Low Beds and Parallel Bars - for the East Indianapolis VA clinicDue October 30, 2026 · Clinical
- FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052Due November 3, 2026 · Clinical
- Nurse Call Upgrade B330 and B320Clinical
View source document →
Source link on usaspending.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- Not stated
- NAICS
- 621511
- PSC
- Q301